Is genotoxicity a suitable biomarker for monitoring anabolic‐androgenic steroids exposure in vivo? A systematic review and meta‐analysis
Journal of Applied Toxicology · 2025-01 · 45 (1) · 77-88
DOI: 10.1002/jat.4656 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Applied Toxicology, online erschienen am 05.06.2024. Verfasst von Thiago Guedes Pinto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences, Institute of Health and Society, Federal University of São Paulo, UNIFESP, Santos, SP, Brazil. Hauptthemen laut MEDLINE: DNA Damage, Anabolic Agents, Biomarkers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Steroids stand for a class of hormones (natural and synthetic) known to be helpful for a number of disorders. Despite the aforementioned beneficial effects of using these hormones, anabolic‐androgenic steroids (AAS) are also widely abused in a non‐therapeutic manner for muscle‐building and strength‐increasing properties that may lead to genotoxicity in different tissues. The present study aims to understand whether genotoxicity may be a suitable biomarker for AAS exposure in vivo in both experimental animal and human studies. All studies published in PubMed/Medline, Scopus, and Web of Science electronic databases that presented data on DNA damage caused by AAS were analyzed. A total of 15 articles were included in this study, and after thoroughly reviewing the studies, a total of 8 articles were classified as Strong, 6 were classified as Moderate, and only 1 was classified as Weak, totaling 14 studies being considered either Strong or Moderate. This classification makes it possible to consider the present findings as reliable. The meta‐analysis data revealed a statistically significant difference in Wistar rat testis cells with AAS compared to control for tail length and % tail DNA (p < 0.001), so that the selected articles were considered homogeneous and the I 2 of 0% indicated low heterogeneity. In summary, genotoxicity can be considered a suitable biomarker for monitoring AAS exposure as a result of DNA breakage and oxidative DNA damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosciences, Institute of Health and Society, Federal University of São Paulo, UNIFESP, Santos, SP, Brazil.
- Department of Diagnosis and Surgery, School of Dentistry, São Paulo State University, UNESP, Araçatuba, SP, Brazil.
ORCID-Profile: Daniel Araki Ribeiro
Zitieren
APA
Pinto, T. G., Malacarne, I. T., Takeshita, W. M., de Barros Viana, M., Renno, A. C. M., & Ribeiro, D. A. (2025). Is genotoxicity a suitable biomarker for monitoring anabolic‐androgenic steroids exposure in vivo? A systematic review and meta‐analysis. Journal of Applied Toxicology, 45(1), 77-88. https://doi.org/10.1002/jat.4656
Vancouver
Pinto TG, Malacarne IT, Takeshita WM, de Barros Viana M, Renno ACM, Ribeiro DA. Is genotoxicity a suitable biomarker for monitoring anabolic‐androgenic steroids exposure in vivo? A systematic review and meta‐analysis. Journal of Applied Toxicology. 2025;45(1):77-88. doi:10.1002/jat.4656
BibTeX
@article{Pinto2025,
author = {Pinto, Thiago Guedes and Malacarne, Ingra Tais and Takeshita, Wilton Mitsunari and de Barros Viana, Milena and Renno, Ana Claudia Muniz and Ribeiro, Daniel Araki},
title = {Is genotoxicity a suitable biomarker for monitoring anabolic‐androgenic steroids exposure in vivo? A systematic review and meta‐analysis},
journal = {Journal of Applied Toxicology},
year = {2025},
volume = {45},
number = {1},
pages = {77--88},
doi = {10.1002/jat.4656}
}
EUVIMED